CME Group Inc. Names Slate of Director Nominees
Prnewswire· 2025-02-06 14:30
CHICAGO, Feb. 6, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today announced its slate of candidates for its board of directors for election at the company's annual meeting to be held Thursday, May 8, 2025.The board of directors recommends the Class A and Class B shareholders voting together elect the following individuals to the board: Terrence A. Duffy, 66, Chairman and Chief Executive Officer, CME Group Kathryn Benesh, 65, CPA, Retired Partner, Deloitte Timothy S. Bi ...
Should You Buy DexCom Stock Before Feb. 13?
The Motley Fool· 2025-02-06 14:30
DexCom (DXCM 0.51%) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels.However, the rising popularity of GLP-1 drugs, which are highly effective in helping people lose weight and also reduce the risk of becoming diabetic, has turned some investors bearish on DexCom's business. If people are slimmer, healthier, and less likely to become diabetic, there would seemingly be less of a need to use CGMs.There's some uncertainty as to how the busin ...
S&P 500 Forecast: Broad Market Edges Higher, But Qualcomm and Arm Weigh on Nasdaq 100
FX Empire· 2025-02-06 14:30
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Essex Property: Shares Have Further Upside Given Limited Housing Supply (Upgrade)
Seeking Alpha· 2025-02-06 14:28
Shares of Essex Property Trust, Inc. (NYSE: ESS ) have been a solid performer over the past year, adding 29% as limited supply in its California markets have enabled higher rental inflation than elsewhere in the nation. GoodOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know!Analyst’s Dis ...
This Could Be the Month That Makes or Breaks Super Micro Computer's Stock
The Motley Fool· 2025-02-06 14:27
Where will Super Micro Computer's (SMCI 2.21%) stock go? That's the big question investors are wondering these days, as there is so much controversy involving the business. If you believe the company's servers will be in high demand by businesses involved in developing artificial intelligence (AI) models, it would be easy to think that the stock looks like it should soar in value in the years ahead. However, if you think the company's financials aren't reliable after its auditor resigned last year, then you ...
Boeing Secures $52M Contract to Support F/A-18 E/F Aircraft
ZACKS· 2025-02-06 14:25
The Boeing Company (BA) recently clinched a deal for the procurement of 175 SUU-79 pylons to aid the F/A-18 E/F aircraft. The award has been provided by the Naval Supply Systems Command Weapon Systems Support, Philadelphia, PA.The deal, valued at $51.6 million, is slated to be completed by February 2029. The work related to this deal will be carried out in Mesa, AZ, and St. Louis, MO.SUU Pylons and Their Advantages SUU pylons are suspension and utility units installed on military aircraft to securely connec ...
Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength?
ZACKS· 2025-02-06 14:25
Ginkgo Bioworks Holdings, Inc. (DNA) shares ended the last trading session 14.5% higher at $16.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 27.6% gain over the past four weeks.The sudden soaring of the stock price can be attributed to positive investor expectations regarding the potential of Ginkgo’s proprietary cell programming platforms, Foundry and Codebase. The company offers R&D services utilizing these ...
VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%
ZACKS· 2025-02-06 14:25
Viking Therapeutics (VKTX) reported a fourth-quarter 2024 loss per share of 32 cents, wider than the Zacks Consensus Estimate of a loss of 27 cents. The company had incurred a loss of 25 cents per share in the year-ago quarter.See the Zacks Earnings Calendar to stay ahead of market-making news.Currently, Viking Therapeutics does not have any approved products in its portfolio. Hence, it is yet to generate revenues.More on VKTX’s Q4 EarningsResearch and development expenses surged 51% year over year to $31 m ...
Huntington Ingalls (HII) Q4 Earnings and Revenues Miss Estimates
ZACKS· 2025-02-06 14:25
Huntington Ingalls (HII) came out with quarterly earnings of $3.15 per share, missing the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $6.90 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.96%. A quarter ago, it was expected that this shipbuilder would post earnings of $3.84 per share when it actually produced earnings of $2.56, delivering a surprise of -33.33%.Over the last four quarters, the c ...
Kenvue's Q4 Sales Miss, Margins Improve
The Motley Fool· 2025-02-06 14:24
Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and Beauty segment.Consumer healthcare products specialist Kenvue (KVUE -0.05%) reported mixed fourth-quarter and full-year earnings on Thursday, Feb. 6. Adjusted earnings per share (EPS) of $0.26 aligned with the market's consensus expectations. Revenue came in at $3.66 billion, falling short of the $3.76 billion estimate and effectively flat when compared to Q4 2023. Despite some headwind ...